Maia Wealth LLC Makes New $364,000 Investment in DaVita Inc. (NYSE:DVA)

Maia Wealth LLC acquired a new stake in DaVita Inc. (NYSE:DVA) in the fourth quarter, HoldingsChannel reports. The fund acquired 2,432 shares of the company’s stock, valued at approximately $364,000.

Several other institutional investors also recently modified their holdings of DVA. Franklin Resources Inc. raised its stake in DaVita by 134.6% in the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after acquiring an additional 31,502 shares during the period. FMR LLC increased its holdings in shares of DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares during the last quarter. Atom Investors LP bought a new position in shares of DaVita in the third quarter valued at about $4,094,000. Assenagon Asset Management S.A. lifted its stake in shares of DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after buying an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new stake in shares of DaVita during the 3rd quarter worth about $726,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Stock Performance

NYSE DVA opened at $147.83 on Monday. The company has a market capitalization of $11.83 billion, a price-to-earnings ratio of 13.76, a PEG ratio of 1.07 and a beta of 0.94. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a twelve month low of $124.70 and a twelve month high of $179.60. The stock has a fifty day simple moving average of $160.66 and a 200 day simple moving average of $158.23.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Sell-side analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Ratings Changes

Several analysts recently weighed in on DVA shares. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Barclays boosted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.